ALGN
Price
$311.88
Change
+$11.06 (+3.68%)
Updated
Apr 23, 6:59 PM EST
One day until earnings call
PROF
Price
$7.70
Change
-$0.04 (-0.52%)
Updated
Apr 23, 6:59 PM EST
13 days until earnings call
Ad is loading...

ALGN vs PROF ᐉ Comparison: Which is Better to Invest?

Header iconALGN vs PROF Comparison
Open Charts ALGN vs PROFBanner chart's image
Align Technology
Price$311.88
Change+$11.06 (+3.68%)
Volume$244.39K
CapitalizationN/A
Profound Medical
Price$7.70
Change-$0.04 (-0.52%)
Volume$5K
CapitalizationN/A
View a ticker or compare two or three
ALGN vs PROF Comparison Chart

Loading...

ALGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PROFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALGN vs. PROF commentary
Apr 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and PROF is a Sell.

COMPARISON
Comparison
Apr 24, 2024
Stock price -- (ALGN: $300.82 vs. PROF: $7.76)
Brand notoriety: ALGN: Notable vs. PROF: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 80% vs. PROF: 26%
Market capitalization -- ALGN: $24.63B vs. PROF: $205.33M
ALGN [@Medical Specialties] is valued at $24.63B. PROF’s [@Medical Specialties] market capitalization is $205.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGN is a better buy in the long-term than PROF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 3 TA indicator(s) are bullish while PROF’s TA Score has 2 bullish TA indicator(s).

  • ALGN’s TA Score: 3 bullish, 7 bearish.
  • PROF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, PROF is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Medical Specialties) experienced а -1.29% price change this week, while PROF (@Medical Specialties) price change was -1.77% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.25%. For the same industry, the average monthly price growth was -3.04%, and the average quarterly price growth was +16.62%.

Reported Earning Dates

ALGN is expected to report earnings on Jul 24, 2024.

PROF is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Medical Specialties (+1.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ALGN with price predictions.
OPEN
A.I.dvisor published
a Summary for PROF with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALGN($24.6B) has a higher market cap than PROF($205M). ALGN YTD gains are higher at: 9.788 vs. PROF (-8.598). ALGN has higher annual earnings (EBITDA): 799M vs. PROF (-26.78M). ALGN has more cash in the bank: 973M vs. PROF (26.2M). PROF has less debt than ALGN: PROF (7.94M) vs ALGN (127M). ALGN has higher revenues than PROF: ALGN (3.86B) vs PROF (7.2M).
ALGNPROFALGN / PROF
Capitalization24.6B205M12,000%
EBITDA799M-26.78M-2,983%
Gain YTD9.788-8.598-114%
P/E Ratio55.01N/A-
Revenue3.86B7.2M53,646%
Total Cash973M26.2M3,714%
Total Debt127M7.94M1,599%
FUNDAMENTALS RATINGS
ALGN vs PROF: Fundamental Ratings
ALGN
PROF
OUTLOOK RATING
1..100
6256
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
9387
SMR RATING
1..100
6597
PRICE GROWTH RATING
1..100
5677
P/E GROWTH RATING
1..100
85100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PROF's Valuation (51) in the null industry is in the same range as ALGN (79) in the Medical Specialties industry. This means that PROF’s stock grew similarly to ALGN’s over the last 12 months.

PROF's Profit vs Risk Rating (87) in the null industry is in the same range as ALGN (93) in the Medical Specialties industry. This means that PROF’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's SMR Rating (65) in the Medical Specialties industry is in the same range as PROF (97) in the null industry. This means that ALGN’s stock grew similarly to PROF’s over the last 12 months.

ALGN's Price Growth Rating (56) in the Medical Specialties industry is in the same range as PROF (77) in the null industry. This means that ALGN’s stock grew similarly to PROF’s over the last 12 months.

ALGN's P/E Growth Rating (85) in the Medical Specialties industry is in the same range as PROF (100) in the null industry. This means that ALGN’s stock grew similarly to PROF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNPROF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 27 days ago
76%
Bullish Trend 27 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
69%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
View a ticker or compare two or three
Ad is loading...
ALGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PROFDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDX38.850.87
+2.29%
Celldex Therapeutics
CCAP17.17N/A
N/A
Crescent Capital BDC
NVT71.17-0.46
-0.64%
nVent Electric plc
EARN6.67-0.05
-0.74%
Ellington Residential Mortgage Reit
KTTA6.76-0.35
-4.92%
Pasithea Therapeutics Corp

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been loosely correlated with SGHT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGN jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
+0.62%
SGHT - ALGN
52%
Loosely correlated
+4.68%
A - ALGN
49%
Loosely correlated
+0.89%
WAT - ALGN
47%
Loosely correlated
+1.06%
IDXX - ALGN
45%
Loosely correlated
+0.68%
XRAY - ALGN
44%
Loosely correlated
-0.43%
More